A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Janssen Research & Development, LLC
- Study ID
- NCT06028438
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Placebo — DRUGPlacebo will be administered intravenously.
- Nipocalimab — DRUGNipocalimab will be administered intravenously.
- Certolizumab — DRUGCertolizumab will be administered subcutaneously.
Study Details
The purpose of this study is to evaluate the efficacy of combination therapy with nipocalimab and certolizumab compared to certolizumab monotherapy.
Key Dates
- Start date
- Aug 15, 2023
- Status verified
- Sep 2025
- Primary completion
- Aug 29, 2024
- Completion
- Oct 29, 2024
Study Design
- Enrollment
- 103 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Certolizumab + PlaceboParticipants will receive placebo intravenously (IV) and certolizumab dose 1 subcutaneously at Week 0, 2, and 4 followed by placebo IV and certolizumab dose 2 subcutaneously at Weeks 6 to 22.
- Experimental: Certolizumab + NipocalimabParticipants will receive nipocalimab IV and certolizumab dose 1 subcutaneously at Week 0, 2, and 4 followed by nipocalimab IV and certolizumab dose 2 subcutaneously at Weeks 6 to 22.
Primary Outcome Measure
Change From Baseline in Disease Activity Index Score 28 Using C-reactive Protein (DAS28-CRP) at Week 12 [ Time Frame: Baseline (Week 0), Week 12 ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arizona Arthritis and Rheumatology Research PLLC | Phoenix | Arizona | 85032 | - |
| Newport Huntington Medical Group | Huntington Beach | California | 92648 | - |
| Inland Rheumatology Clinical Trials Inc. | Upland | California | 91786 | - |
| Bay Area Arthritis and Osteoporosis | Brandon | Florida | 33511 | - |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | - |
| Integral Rheumatology And Immunology Specialists | Plantation | Florida | 33324 | - |
| Atlanta Research Center for Rheumatology | Marietta | Georgia | 30060 | - |
| Graves Gilbert Clinic | Bowling Green | Kentucky | 42101 | - |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | - |
| Southwest Rheumatology Research LLC | Mesquite | Texas | 75150 | - |
Related coverage on Hipa.ai
- Nipocalimab + Certolizumab for RA: Phase 2 Shows No Significant DAS28-CRP…Nipocalimab · Oct 16, 2025 · ClinicalTrials.gov
Find similar trials in Phoenix, AZ
By condition
By research site
Arizona Arthritis and Rheumatology Research PLLC· Phoenix, AZNewport Huntington Medical Group· Huntington Beach, CAInland Rheumatology Clinical Trials Inc.· Upland, CABay Area Arthritis and Osteoporosis· Brandon, FLClinical Research of West Florida· Clearwater, FLIntegral Rheumatology And Immunology Specialists· Plantation, FL
Related Studies
- R-2487 in Patients With Rheumatoid ArthritisPHASE1 · Recruiting · Rise Therapeutics LLC · San Diego, California
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Glendale, Arizona
- A Study of BMS-986528 in Participants With Refractory Rheumatoid ArthritisPHASE1/PHASE2 · Not Yet Recruiting · Bristol-Myers Squibb · Aurora, Colorado
- Laser-based Photoacoustic Tomography of Human Inflammatory ArthritisRecruiting · University of Michigan · Ann Arbor, Michigan